DNA-based nanotechnology stimulates potent antitumor immune responses0
- From Around the Web, Science & Technology
- September 10, 2020
Synthetic DNA nanovaccines enhance killer T cell immunity resulting in tumor control in preclinical studies
Synthetic DNA nanovaccines enhance killer T cell immunity resulting in tumor control in preclinical studies
If a tree falls in a forest and no one is there to hear it, does it make a sound? Perhaps not, some say.
Researchers have made a discovery that could potentially lead to the development of a new treatment for the most common childhood cancer: acute lymphoblastic leukemia.
In a new study to be published in the Monthly Notices of the Royal Astronomical Society, a research team led by University of Manchester astronomers extended a sample of 1,327 stellar systems recently observed by the Breakthrough Listen Initiative by including additional 288,315 stars that also reside within the target fields of the Robert C. Byrd Green Bank Telescope in West Virginia and CSIRO’s Parkes radio telescope in Australia — increasing the number of stars analyzed by a factor of more than 200. Their results suggest that less than 0.04% of stellar systems have the potential of hosting advanced civilizations with the equivalent or slightly more advanced radio technology than 21st century humans.
Nanotheranostics, integrating diagnostic and therapeutic functions by nanoplatform, exhibits a great potential in precision and personalized medicine, and also raises the requirement on multifunctional nanomaterials in pursuit of both good biocompatibility and high theranostic performance.
The sub could be ready to launch in the 2030s, researchers said.
Billionaire entrepreneur Elon Musk’s neuroscience startup Neuralink on Friday unveiled a pig that has had a coin-sized computer chip in its brain for two months, demonstrating an early step toward the goal of curing human diseases with the same type of implant.
Changing the world, bit by bit
Dead outer microbes protect inner ones in clumps attached to the International Space Station
A property of positronium—an exotic atom consisting of an electron bound to its antimatter partner, a positron—differs significantly from theoretical predictions, a team of physicists reports.